COMP <GO>
AUNA vs SRTA // EV/EBITDA & P/E VALUATION
Auna SA (Class A) (NYSE) VS. Strata Critical Medical Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: AUNA 0
— SRTA 2
■ METRIC PARITY
LAST: $4.80 (+1.27%) • MKT CAP: $355.3M
valuation
—
LAST: $4.75 (-0.21%) • MKT CAP: $420.2M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AUNA VS. SRTA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AUNA | SRTA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 20.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -7.10% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -13.92% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -11.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 21.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 34.30% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.58 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 4/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.8 | 36.4 | -6.65 | SRTA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 8.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $355.3M | $420.2M | -$65.0M | SRTA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AUNA REV | SRTA REV | AUNA GROSS % | SRTA GROSS % | AUNA FCF | SRTA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $197.1M | — | 20.9% | — | -$58.5M |
| FY 2024 | — | $146.8M | — | 20.2% | — | -$33.4M |
| FY 2023 | — | $225.2M | — | — | — | -$32.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AUNA // BETA —
SRTA // BETA —